1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Hepáticas y Digestivas

Enfermedades Hepáticas y Digestivas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Taxonera C, Barreiro-de Acosta M, Bastida G, Martínez-González J, Merino O, García-Sánchez V, Gisbert JP, Marín-Jiménez I, López-Serrano P, Gómez-García M, Iglesias-Flores E, Lopez-Sanroman A, Chaparro M, Saro C, Bermejo F, Pérez-Carazo L, Plaza R, Olivares D, Alba C, Mendoza JL, Fernández-Blanco I.

    Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease.

    JOURNAL OF CROHNS & COLITIS . 10(6): 657-662. Nº de citas: 18

    [doi:10.1093/ecco-jcc/jjw016]

  • Albillos A, Martínez J, Téllez L.

    Continued controversy over the safety of beta-blockers in decompensated cirrhosis.

    HEPATOLOGY . 63(5): 1726-1729.

    [doi:10.1002/hep.28293]

  • Úbeda M, Lario M, Muñoz L, Borrero MJ, Rodríguez-Serrano M, Sánchez-Díaz AM, Del Campo R, Lledó L, Pastor Ó, García-Bermejo L, Díaz D, Álvarez-Mon M, Albillos A.

    Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats.

    JOURNAL OF HEPATOLOGY . 64(5): 1049-1057. Nº de citas: 85

    [doi:10.1016/j.jhep.2015.12.010]

  • Abraldes JG, Villanueva C, Aracil C, Turnes J, Hernandez-Guerra M, Genesca J, Rodriguez M, Castellote J, García-Pagán JC, Torres F, Calleja JL, Albillos A, Bosch J.

    Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.

    Gastroenterology . 150(5): 1160-1160. Nº de citas: 155

    [doi:10.1053/j.gastro.2016.01.004]

  • Guerra I, Pérez-Jeldres T, Iborra M, Algaba A, Monfort D, Calvet X, Chaparro M, Mañosa M, Hinojosa E, Minguez M, Ortiz de Zarate J, Márquez L, Prieto V, García-Sánchez V, Guardiola J, Rodriguez GE, Martín-Arranz MD, García-Tercero I, Sicilia B, Masedo Á, Lorente R, Rivero M, Fernández-Salazar L, Gutiérrez A, Van Domselaar M, López-SanRomán A, Ber Y, García-Sepulcre M, Ramos L, Bermejo F, Gisbert JP.

    Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study

    INFLAMMATORY BOWEL DISEASES . 22(4): 894-901. Nº de citas: 53

    [doi:10.1097/MIB.0000000000000757]

  • de la Coba Ortiz C, Argüelles Arias F, Martín de Argila de Prados C, Júdez Gutiérrez J, Linares Rodríguez A, Ortega Alonso A, Rodríguez de Santiago E, Rodríguez-Téllez M, Vera Mendoza MI, Aguilera Castro L, Álvarez Sánchez Á, Andrade Bellido RJ, Bao Pérez F, Castro Fernández M, Giganto Tomé F.

    Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.

    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS . 108(4): 207-224. Nº de citas: 33

    [doi:10.17235/reed.2016.4232/2016]

  • Piqué N, Ponce M, Garrigues V, Rodrigo L, Calvo F, de Argila CM, Borda F, Naranjo A, Alcedo J, José Soria M, Rey E, Bujanda L, Gisbert JP, Suarez D, Calvet X, Ponce J.

    Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study).

    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL . 4(2): 229-235. Nº de citas: 7

    [doi:10.1177/2050640615595916]

  • Rodríguez-D'Jesús A, Fernández-Esparrach G, Marra-Lopez C, Orive-Calzada A, Arribas J, Sendino O, Araujo I, Rodríguez de Miguel C, Vázquez-Sequeiros E, Córdova H, Sánchez-Montes C, González-Suárez B, Ginès A.

    Adverse events of EUS-guided FNA of pancreatic cystic and solid lesions by using the lexicon proposed in an ASGE workshop: a prospective and comparative study

    GASTROINTESTINAL ENDOSCOPY . 83(4): 780-784. Nº de citas: 12

    [doi:10.1016/j.gie.2015.08.035]

  • Aguilera Castro L, Martín de Argila de Prados C, Albillos Martínez A.

    Practical considerations in the management of proton-pump inhibitors.

    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS . 108(3): 145-153.

    [doi:10.17235/reed.2015.3812/2015]

  • Senosiain C, González-Tallón A A, López-Sanromán A, Mateos ML, Pérez-Gracia MT, García-Sánchez MC, Maroto M, Garrido E.

    Hepatitis E seroprevalence in inflammatory bowel disease

    GASTROENTEROLOGIA Y HEPATOLOGIA . 39(3): 185-190. Nº de citas: 6

    [doi:10.1016/j.gastrohep.2015.06.004]

  • Zeuzem S, Hézode C, Bronowicki JP, Loustaud-Ratti V, Gea F, Buti M, Olveira A, Banyai T, Al-Assi MT, Petersen J, Thabut D, Gadano A, Pruitt R, Makara M, Bourlière M, Pol S, Beumont-Mauviel M, Ouwerkerk-Mahadevan S, Picchio G, Bifano M, McPhee F, Boparai N, Cheung K, Hughes EA, Noviello S, LEAGUE-1 Study Team.

    Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection

    JOURNAL OF HEPATOLOGY . 64(2): 292-300. Nº de citas: 34

    [doi:10.1016/j.jhep.2015.09.024]

  • Villanueva C, Albillos A, Genescà J, Abraldes JG, Calleja JL, Aracil C, Bañares R, Morillas R, Poca M, Peñas B, Augustin S, Garcia-Pagan JC, Pavel O, Bosch J.

    Development of hyperdynamic circulation and response to ß-blockers in compensated cirrhosis with portal hypertension.

    HEPATOLOGY . 63(1): 197-206. Nº de citas: 90

    [doi:10.1002/hep.28264]

  • Lens, Sabela, Rincon, Diego, Garcia-Retortillo, Montserrat, Albillos, Agustin, Luis Calleja, Jose, Banares, Rafael, Gonzalez Abraldes, Juan, Bosch, Jaume, Maria Sanchez-Tapias, Jose, Forns, Xavier, Carlos Garcia-Pagan, Juan.

    Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association . 13(10): 1846-204. Nº de citas: 40

    [doi:10.1016/j.cgh.2015.04.013]

  • Angeli P, Rodríguez E, Piano S, Ariza X, Morando F, Solà E, Romano A, García E, Pavesi M, Risso A, Gerbes A, Willars C, Bernardi M, Arroyo V, Ginès P, for the CANONIC Study Investigators of the EASL-CLIF Consortium.

    Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis

    Gut . 64(10): 1616-1622. Nº de citas: 58

    [doi:10.1136/gutjnl-2014-307526]

  • Mocci E, Guillen-Ponce C, Earl J, Marquez M, Solera J, Salazar-López MT, Calcedo-Arnáiz C, Vázquez-Sequeiros E, Montans J, Muñoz-Beltrán M, Vicente-Bártulos A, González-Gordaliza C, Sanjuanbenito A, Guerrero C, Mendía E, Lisa E, Lobo E, Martínez JC, Real FX, Malats N, Carrato A.

    PanGen-Fam: Spanish registry of hereditary pancreatic cancer

    EUROPEAN JOURNAL OF CANCER . 51(14): 1911-1917. Nº de citas: 32

    [doi:10.1016/j.ejca.2015.07.004]

  • Martinez-Gonzalez, Javier, Lopez-Duran, Sergio, Vazquez-Sequeiros, Enrique, Albillos-Martinez, Agustin.

    Management of fundic varices. Endoscopic aspects

    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS . 107(8): 501-508.

  • Téllez Villajos L, Martínez González J, Moreira Vicente V, Albillos Martínez A.

    Pulmonary hypertension and hepatic cirrhosis

    REVISTA CLINICA ESPANOLA . 215(6): 324-330. Nº de citas: 1

    [doi:10.1016/j.rce.2015.02.019]

  • Cerini F, Gonzalez JM, Torres F, Puente Á, Casas M, Vinaixa C, Berenguer M, Ardevol A, Augustin S, Llop E, Senosiaín M, Villanueva C, de la Peña J, Bañares R, Genescá J, Sopeña J, Albillos A, Bosch J, Virginia-Hernández-Gea , Garcia-Pagán JC.

    Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

    HEPATOLOGY . 62(2): 575-583. Nº de citas: 64

    [doi:10.1002/hep.27783]